CPS
  • Home

Sign in or register to track your progress, save, and view your completed history.

Breast Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head & Neck Cancer, Lung Cancer, Urothelial Carcinoma​

External Quality Assurance of PD-L1 Assays: The NordiQC experience

    clockimg 54m
  • Webinar
  • Intermediate
 saveimgSave unsaveimgUnsave

The Precision Pathology Insights webinar series brings you expert PD-L1 evaluation insights. Since 2017, the series has provided key perspectives from industry leaders to help sharpen your Combined Positive Score (CPS) expertise and PD-L1 evaluation skills. This webinar is presented by Dr. Mogens Vyberg, MD. Recorded on 4 December 2019.​

 

Dr. Mogens Vyberg delivers expert insights on the topic of external quality assurance of PD-L1 assays. Key topics covered are:​

  • Independent insight and observations from a global IHC external quality control organization (NordiQC)​
  • Consideration and recommendations for IHC assay selection and diagnostic use​
  • Validation considerations for laboratory developed tests​
Mogens Vyberg, MD​ Professor​, Consultant, NordiQC​, Aalborg University, Denmark

Mogens Vyberg, MD​

Professor​, Consultant, NordiQC​ - Aalborg University, Denmark

Related Training

This website discusses general principles for CDx scoring and is intended for educational purposes only. Not all cancer indications mentioned are approved worldwide. Please consult local Instructions for Use for more information.D0113743_1.00